The Stockholm stock exchange is rising in early Tuesday trading. Q-linea is gaining on a first commercial agreement in the US and Arjo is trading up after a change of CEO and preliminary figures for the fourth quarter.

After 22 minutes of trading, the OMXS30 index was up 0.78 percent to 2,534.37. During the day, the index has moved within the range of 0.65 percent at its lowest and 0.83 percent at its highest.

The broad OMXSPI was up 0.91 percent.

Share pricePrice changeCommentary
Q-Linea 99,1%Writes first commercial contract in the US
Irlab 7,5%All patients in phase 2b study have undergone final follow-up visit
Arjo 5,9%Announces change of CEO and releases preliminary figures
Mycronic 4,8%Handelsbanken raises to Buy (Hold) in the short term, Market Perform (Underperform) in the long term
Sagax 4,3%Carnegie raises to buy from hold, lowers target price to SEK 250 from SEK 275
Sinch 3,8%Morgan Stanley raises to equal weight from underweight, target price SEK 20.50
Fabege 2,3%Nordea raises to hold from sell, Kempen raises to neutral (sell) and SHB reiterates buy
Epiroc 2,2%Pareto raises to buy from hold, reiterates target price SEK 235, ABG also raises to buy
Bioarctic 1,6%FDA has received application from partner Eisai for Leqembi subcutaneous maintenance treatment
Atrium Ljungberg 1,7%Carnegie raises to hold from sell, lowers target price to SEK 200 from SEK 210
Swedbank 0,3%Arctic lowers to hold from buy, target price SEK 250
SLP-0,3%Kempen lowers to neutral from buy, target price SEK 42
NCAB-2,1%Pareto Securities downgrades to hold from buy, reiterates target price SEK 69